NCT00177138 Use of Campath for Induction and Maintenance Therapy in Pancreas After Kidney Transplantation Status TERMINATED Phase PHASE4
NCT00171496 Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation Recipients Status COMPLETED Phase PHASE4
NCT00163657 Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection Status COMPLETED Phase PHASE4
NCT00157014 Canadian Cardiology de Novo Study: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens Status COMPLETED Phase PHASE3
NCT00151632 Reduction of Tacrolimus Dose in Association With Mycophenolate Mofetil After Liver Transplantation Status TERMINATED Phase PHASE3
NCT00150891 Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection Status COMPLETED Phase N/A
NCT00149994 Cyclosporine A C-2h Monitoring Versus Tacrolimus C-0h Monitoring in de Novo Liver Transplant Recipients Status COMPLETED Phase PHASE4
NCT00148746 Standardized Time- and Score-oriented Treatment of Moderate and Severe Atopic Dermatitis Status COMPLETED Phase NA
NCT00147381 Effectiveness and Safety of Campath in Combination With Tacrolimus Monotherapy to Prevent Kidney Graft Rejection Status COMPLETED Phase PHASE3
NCT00146614 Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell Transplantation Status COMPLETED Phase PHASE2
NCT00144703 Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation Status COMPLETED Phase PHASE2
NCT00144677 Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation Status COMPLETED Phase PHASE2
NCT00141037 Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) Transplantation Status COMPLETED Phase PHASE1/PHASE2
NCT00136903 Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD) Status COMPLETED Phase PHASE2
NCT00134004 Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer Status COMPLETED Phase PHASE2
NCT00133887 TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients Status COMPLETED Phase PHASE3
NCT00133367 Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus Status COMPLETED Phase PHASE2
NCT00133172 Effect of Rapid Steroid Withdrawal on Subclinical Markers of Rejection Status TERMINATED Phase PHASE4
NCT00125307 Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis Status COMPLETED Phase PHASE4
NCT00121186 S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed Lymphoma Status TERMINATED Phase PHASE2